Prof. M.D. Ali Aydın YAVUZ

Lung Cancers
Head and Neck Cancers
Brain Tumors
Breast Cancers
Digestive System Cancers
Urological Cancers
Gynecological Cancers
Skin Cancers
Connective and Soft Tissue Tumors

1997-2006 Karadeniz Technical University Radiation Oncology Department Head
2006-2009 Baskent University Department of Radiation Oncology
2006-2009 Baskent University Adana Barracks Campus Chief Physician
In 2008, he visited MD Anderson Cancer Center's Lung, Digestive System, Head and Neck and Gynecological Cancer clinics for professional knowledge and manners.
2009-2018 Akdeniz University Faculty of Medicine, Department of Radiation Oncology, Faculty Member.
He made the first Oral Presentations on behalf of our country at the ASCO congresses in 1999 and ASTRO in 2000.

Turkish Oncology Association
Turkish Radiation Oncology Association
European Society for Therapeutic Radiology and Oncology (ESTRO)
European Association for Cancer Research (EACR)
European Society of Medical Oncology (ESMO)
American Society for Therapeutic Radiology and Oncology (ASTRO)
American Society of Clinical Oncology (ASCO)
He is a member of the European Organization for Research and Treatment of Cancer (EORTC).

prof. Dr. Ali Aydın Yavuz has many international publications published in the SSCI and has more than 1000 citations to these publications, and he still ranks at the top of the Turkish Radiation Oncology community in the H-Index ranking for citations to publications.

prof. Dr. Ali Aydın Yavuz has more than 160 national and international publications and presentations in meetings.

A. International articles published in international refereed journals:
A1. Yavuz AA, Yavuz MN, Ozgur GK, Colak F, Ozyavuz R, Cimsitoglu E, Ilis E., ''Accelerated Superfractionated Radiotherapy with Concomitant Boost for Invasive Bladder Cancer'', INT J RADIAT ONCOL BIOL PHYS 56(3), 734- 745 (2003)
A2. Yavuz MN, Yavuz AA, Aydın F, Can G, Kavgacı H., ''The Efficacy Of Octreotide In The Therapy Of Acute Radiation-Induced Diarrhea: A Randomized Controlled Study'', INT J RADIAT ONCOL BIOL PHYS 54(1), 195-202 (2002)
A3. Yavuz AA, Yaris N, Yavuz MN, Sari A, Reis A, Aydin F., ''Primary Intraspinal Primitive Neuroectodermal tumor: A case report of a tumor literature arising from the sacral spinal nerve root and review of the'', AMERICAN JOURNAL OF CLINICAL ONCOLOGY, 25(2), 135-139 (2002).
A4. Abstract A, Yavuz AA, Kömürcü Ş, Öztürk B, Safali M, Arpacı F, Caliskaner Z., ''Bilateral male breast cancer and prostate cancer : a case report'', JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 30(4), 188 -190 (2000).
A5. Ozet A, Yavuz AA, Ozturk B, Komurcu S, Arpaci F, Tuvay E, Tezcan Y., ''Recurrent spontaneous pneumothorax following high-dose chemotherapy in a patient with non-seminomatous testicular cancer with pulmonary metastases'', TUMORI, 86 (3), 253-255 (2000).
A6. Aydın F, Yılmaz M, Özdemir F, Kavgacı H, Yavuz MN, Yavuz AA.,''The Correlation of serum IL-2, IL-6 and IL-10 Levels with International Prognostic Index in Patients with Agressive Non-Hodgkin's Lymphoma' ', AMERICAN JOURNAL OF CLINICAL ONCOLOGY, 25(6), 570-572 (2002).
A7. Abstract A, Arpaci F, Yilmaz I, Ayta H, Ozturk B, Komurcu S, Yavuz AA, Tezcan Y, Acikel C., ''Effects of tamoxifen on the serum leptin level in patients with breast cancer'', JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 31(9), 424-427 (2001).
A8. Ozet A, Yilmaz MI, Yavuz AA, Ozturk B, Komurcu S, Arpaci F.,''A 10-year delayed breast cancer patient with unusual widespread cutaneous involvement and visceral metastases'', BREAST J, 9(1), 54- 55 (2003).
A9. Kavgaci H, Ozdemir F, Aydin F, Yavuz AA, Yavuz MN. “Endogenous granulocyte Colony-Stimulating factor (G-CSF) levels in Chemotherapy-Induced neutropenia and in neutropenia related with primary Diseases”, J EXP CLIN CANCER RES, 21(4), 475-479 (2002)
A10. Kosucu P, Yavuz AA, Yavuz MN, Reis A, Ahmetoglu A. “Primary intracranial malignant fibrous histiocytoma: case report”, EUR J RADIOL E, 47(2), 78-81 (2003)
A11. Yavuz MN, Yavuz AA, Ulku C, Sener M, Yaris E, Kosucu P, Karslioglu I. ''Protective effect of melatonin against fractionated irradiation-induced epiphyseal injury in a weanling rat model'', J PINEAL RES, 35(4) , 288-94 (2003).
A12. Yavuz AA, Sener M, Yavuz MN, Kosucu P, Cobanoglu U. “Aneurysmal Bone Cyst of the Sternum: A case report of successful treatment with radiotherapy”, BRITISH JOURNAL OF RADIOLOGY, 77, 610-614, 2004.
A13. Yaris N, Yavuz MN, Reis A, Yavuz AA, Okten A. Primary cerebral neuroblastoma: a case treated with adjuvant chemotherapy and radiotherapy. TURK J PEDIATR, 46(2):182-5, 2004.
A14. Ozdemir F, Aydin F, Kavgacı H, Bektas O, Yavuz MN, Yavuz AA. ‘The effects of IL-2, IL-6 and IL-10 levels on prognosis in patients with aggressive Non-Hodgkin’s lymphoma’, JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 23(3):485-8, 2004.
A15. Yavuz AA, Cobanoglu U, Yavuz MN, Kosucu P, Kavgacı H, Reis AK, Aslan MK. ‘Malignant Fibrous Histiocytoma of the Thyroid Gland: recurrence Succesfully Treated by Radiotherapy’, THE JOURNAL OF OTOLARYNGOLOGY, 34(3):216-20, 2005.
A16. Kavgaci H, Ozdemir F, Ovali E, Yavuz AA, Yavuz MN, Aydin F. Effect of the farnesyl transferase inhibitor L-744,832 on the colon cancer cell line DLD-1 and its combined use with radiation and 5-FU. CHEMOTHERAPY, 51(6):319-23, 2005.
A17. Cengiz M, Ozyar E, Esassolak M, Altun M, Akmansu M, Sen M, Uzel O, Yavuz AA, Dalmaz G, Uzal C, Hicsonmez A, Sarihan S, Kaplan B, Atasoy BM, Ulutin C, Abacioglu U, Demiral AN , Hayran M. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules. INT J RADIAT ONCOL BIOL PHYS. 2005;63(5): 1347-53, 2005.
A18. Genc M, Yavuz MN, Cimsit G, Cobanoglu U, Yavuz AA. Radiation Port Wart: A Distinct Cutaneous Lesion After Radiotherapy (A case report). J NATL MED ASSOC 98(7): 1193-6, 2006.
A19. Kömürcü S, Turhal S, Altundağ K, Atahan L, Turna HS, Manavoğlu O, Yavuz AA, Ozkök S, Aliustaoğlu M, Altinbaş M, Pak Y, Cooper R, Yaylaci M, Demirkan B, Sarihan S, Ozdemir F. Safety and efficacy of transdermal fentanyl in patients with cancer pain: phase IV, Turkish oncology group trial. EUR J CANCER CARE (Engl). 2007 Jan;16(1):67-73.
A20

. Topkan E, Yavuz MN, Onal C, Yavuz AA.: Prevention of acute radiation-induced esophagitis with glutamine in non-small cell lung cancer patients treated with radiotherapy: Evaluation of clinical and dosimetric parameters. LUNG CANCER 2009 Mar;63(3):393-9.

A21. Topkan E, Tufan H, Yavuz AA, Bacanli D, Onal C, Kosdak S, Yavuz MN.Comparison of the Protective Effects of Melatonin and Amifostine on Radiation-Induced Epiphyseal Injury. INT J RADIAT BIOL; 2008 Oct;84(10):796-802.

A22. Topkan E, Yavuz AA, Aydin M, Onal C, Yapar F, Yavuz MN.: Comparison of Ct and PET-CT Based Planning of Radiation Therapy in Locally Advanced Pancreatic Carcinoma. J EXP CLIN CANCER RES 2008, 27:41

A23. Topkan E, Onal C, Yavuz MN, Yavuz AA: Pathophysiology and treatment of radiation-induced brachial plexopathy. INT J HEMATOL ONCOL 4, 180-185 (2008).

A24. Demiral AN, Alicikus ZA, Işil Ugur V, Karadogan I, Yöney A, Andrieu MN, Yalman D, Pak Y, Aksu G, Ozyigit G, Ozkan L, Kilçiksiz S, Koca S, Caloğlu M, Yavuz AA, Başak Cağlar H, Beyzadeoğlu M, Iğdem S, Serin M, Kaplan B, Koç M, Korkmaz E, Karakoyun-Celik O, Dinçer S, Kinay M. Patterns of care for lung cancer in radiation oncology departments of Turkey. INT J RADIAT ONCOL BIOL PHYS. 2008 Dec 1;72(5):1530-7. Epub 2008 Aug 15.

A25. Topkan E, Yavuz AA, Ozilkan O. Cancer cachexia: pathophysiologic aspects and treatment options. ASIAN PAC J CANCER PREV. 2007 Jul-Sep;8(3):445-51. review.

A26. Yavuz AA, Topkan E, Onal C, Yavuz MN: Prophylactic cranial irradiation in locally advanced non-small cell lung cancer: outcome of recursive partitioning analysis group 1 patients. J EXP CLIN CANCER RES. 2008 Dec 4;27:80.

  A27. Onal C, Topkan E, Efe E, Yavuz M, Sonmez S, Yavuz AA. Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis. RADIAT ONCOL. 2009 May 11;4:14.
         
A28. Yavuz MN, Topkan E, Yavuz AA, Aydın M, Onal C, Reyhan M, Yapar AF. FDG-PET/CT Imaging Based Target Volume Delineation For Preoperative Conformal Radiotherapy Of Rectal Carcinoma. INT J HEMATOL ONCOL 2010, Vol 20, Num 2 Page(s): 067-074.

A29. Onal C, Topkan E, Efe E, Yavuz MN, Arslan G, Yavuz AA. The effect of concurrent androgen deprivation and 3D conformal radiotherapy on prostate volume and clinical organ doses during the course of treatment in prostate cancer. BrJ Radiol. 2009 Dec;82(984):1019-26. Epub 2009 Jul 6.

A30. Pehlivan B, Topkan E, Onal C, Nursal GN, Yuksel O, Dolek Y, Yavuz MN, Yavuz AA. Comparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma. Radiat Oncol. 2009 Sep 16;4:35.

A31. Onal C, Arslan G, Topkan E, Pehlivan B, Yavuz M, Oymak E, Yavuz AA. Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses. J Exp Clin Cancer Res. 2009 Jul 1;28:95.

A32. Yavuz AA, Aydin F, Yavuz MN, Ilis E, Ozdemir F. Radiation therapy and concurrent ixed dose amifostine with escalating doses of twicw-weekly gemcitabine in advanced pancreatic cancer. Int J Radiat Oncol Biol Phys
  2001 Nov 15;51(4):974-81.

A33. Onal C, Kayaselcuk F, Topkan E, Yavuz M, Bacanli D, Yavuz AA. Protective effects of melatonin and octreotide against radiation-induced intestinal injury. DigDis Sci. 2011 Feb;56(2):359-67.

A34. Onal C, Kotek A, Unal B, Arslan G, Yavuz AA, Topkan E, Yavuz MN. Plasma citrulline levels predict intestinal toxicity in patients treated with pelvic radiotherapy. Acta Oncol. 2011 Nov;50(8):1167-74. Epub 2011 Aug 24.

A35. Onal C, Topuk S, Yapar AF, Yavuz MN, Topkan E, Yavuz AA. Comparison of computed tomography- and positron emission-tomography based radiotherapy planning in cholangiocarcinoma. oncology. 2013;36(9):484-90.

A36. Kaya V, Korcum Şahin AF, Yıldırım M, Aksu MG, Sirin Ozdemir B, Yavuz AA. Clinicopathologic prognostic factors in locally advanced pancreatic cancer patients treated with radiotherapy. J Clin Analytical Med. 2014:707-711.

B. Papers presented at international scientific meetings and published in the proceedings book:
B1. Yavuz AA,Yavuz MN, Reis A, Bahat Z, İliş E, Özgür GK, Aydın F, Özoran Y., ''The Effects of Retinoblastoma Protein Expression on the Radiation Response of Bladder Cancer (Poster)'', 19'th ESTRO (European Society for Therapeutic Radiology and Oncology) Annual Meeting, Istanbul, Radiotherapy & Oncology, Vol. 56 (Suppl 1), 175, Elsevier, 2000.
B2. Yavuz MN, Yavuz AA, Çakırbay H, Bahat Z, İliş E, Aydın F., Uzuner H., '' Effects of Pamidronate Use on the Palliative Radiotherapy of Bone Metastases: A Prospective Randomized Study (Oral Presentation), 42'nd ASTRO (American Society for Therapeutic Radiology and Oncology) Annual Meeting, Boston, International Journal of Radiation Oncology Biology Physics, Vol. 48, 185-186, Elsevier, 2000.
B3. Yavuz AA., Yılmaz M, Aydın F, Özdemir F, Yavuz MN, Kavgacı H., İliş E., ''Correlations of serum IL-2, IL-6 and IL-10 with International Prognostic Index in patients with Non-Hodgkin Lymphoma (Poster)'', 37'th ASCO (American Society of Clinical Oncology) Annual Meeting, San Francisco, Journal of Clinical Oncology, Vol 20, Part 1, 435, Lippincott Williams & Wilkins, 2001
B4. Alkaya F, Bones G, Yavuz MN, Gürsoy TO, Yavuz AA., Baş M, ''Effects of the shielding blocks on dose parameters of radiotherapy with Co 60 machine'', 17'th ESTRO (European Society for Therapeutic Radiology and Oncology) ) Annual Meeting, Edinburgh, Radiotherapy Oncology Vol 48 ( Suppl. 1 ), 50, Elsevier, 1998.
B5. Yavuz MN, Iliş E, Yavuz AA, Ovalı E, Aydın F, Uzuner H., ''The effects of megestrol acetate in cachectic cancer patients receiving radiotherapy on cachexia-related parameters and serum IL-1 beta and TNF-alpha levels'' , 37'th ASCO (American Society of Clinical Oncology) Annual Meeting, San Francisco, Journal of Clinical Oncology, Vol 20, Part 2, 306, Lippincott Williams & Wilkins, 2001.
B6. Yavuz MN, Yavuz AA, İliş E, Bahat Z, Aydın F., ''A Randomized Study of the Efficacy of Octreotide Versus Diphenoxylate on Radiation- Induced Diarrhea (Oral Presentation)'', 36'th ASCO (American Society of Clinical Oncology) ) Annual Meeting, New Orleans, Journal of Clinical Oncology. Vol. 19, 602, Lippincott Williams & Wilkins, 2000.
B7. Aydın F, Ovalı E, Ozdemir F, Yavuz AA, Kavgacı H, Yavuz MN., ''The effects of ATRA, Vitamin D3 and Dexamethasone on Acute Myeloid Leukemic Cells'', 37'th ASCO (American Society of Clinical Oncology) Annual Meeting, San Francisco, Journal of Clinical Oncology, Vol 20, Part 2, 237, Lippincott Williams & Wilkins, 2001.
B8. Yavuz AA, Cimşitoğlu E, Yavuz MN, Çolak F, İliş E, Bahat Z., ''Impact of Cradle Immobilization on Set-up Error During External Radiotherapy for Non-small Cell Lung Cancer (Poster)'', Fourth Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO), St. Gallen, Strahlentherapie Oncologie Vol. 176(4) Supp 1, Springer, 2000.
B9. Abstract A, Arpacı F, Kömürcü Ş, Öztürk B, Yılmaz I, Ayta H, Yavuz AA, Pak Y, Yücel İ, Yalçın A, ''High Dose Chemotherapy (HDC) and Autologous Peripheral Blood Stem Cell Transplantation (APBSCT) for 45 Patients With Breast Cancer: Results of the Most Experienced Center in Turkey', 36 'th ASCO (American Society of Clinical Oncology) Annual Meeting, New Orleans, Journal of Clinical Oncology. Vol. 19, 68, Lippincott Williams & Wilkins, 2000.
B10. Yavuz MN, Akyol F, Yavuz AA, Özyar E, Atahan İL., ''Accelerated fractionation with concomitant boost technique in radiotherapy of carcinoma of the urinary bladder'', 17'th ESTRO (European Society for Therapeutic Radiology and Oncology) Annual Meeting , Edinburgh, Radiotherapy Oncology Vol 48 (Suppl. 1), 86, Elsevier, 1998.
B11. Komurcu S, Turhal S, Altundag K, Atahan L, Turna HS, Manavoglu O, Yavuz AA, Ozkok S, Aliustaoglu M, Altınbas M, Pak Y, Cooper R, Yaylacı M, Demirkan B, Engin K, Ozdemir F. Turkish Oncology Group, Supportive Care Study Group. A clinical evaluation of transdermal fentanyl in adults with cancer pain: phase IV, multicentre trial (Poster). 15th Multinational Assaciation of Supportive Care in Cancer International Symposium, Berlin, Germany, Supportive Care in Cancer, Vol 11(6), A-39, Springer, 2003.
B12. Yavuz AA, Bahat Z, Kavakçı O, Yavuz MN, Tezcan Y, Uzuner H., ''Radiation Treatment in Geriatric Patients : Effects on Nutrition, Performance, Comorbidity, Psychsocial Functions and Quality of Life. (Poster)'', Fourth Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO), St. Gallen, Strahlentherapie Oncologie Vol. 176(4) Supp 1, Springer, 2000.
B13. Abstract A, Arpacı F, Yılmaz İ, Ayta H, Öztürk B, Yavuz AA, Tezcan Y, Açıkel C, Özata M., ''The role of tamoxifen on serum leptin level in patients with breast cancer (Poster)'', 25 'th ESMO Congress, Hamburg, Annals of Oncology Vol 11(Suppl 4), 14, Kluwer, 2000.
B14. Yavuz AA, Yavuz MN, İliş E, Yaris N., Aydın F., Bahat Z, ''A Randomized Study of the Efficacy of Octreotide Versus Diphenoxylate on Radiation-Induced Diarrhea (Oral Presentation)'', 19 th ESTRO ( European Society for Therapeutic Radiology and Oncology) Annual Meeting, Istanbul, Radiotherapy & Oncology, Vol. 56 (Suppl 1), 18, Elsevier, 2000.
B15. Özyar E, Uzal D, Yavuz AA, Akyol F, Atahan İL., ''Adjuvant High dose rate brachytherapy boost after external radiotherapy in patients with nasopharyngeal cancer'', International Congress of Radiation Oncology (ICRO'97), Beijing, China, 1997.
B16. Yavuz AA, Kömürcü Ş, Isıkhan V, Güner P, Abstract A, Öztürk B, Arpacı F., ''The relation between several disease features in cancer patients and their quality of life (Poster)'', 25'th European Society of Medical Oncology (ESMO) Congress, Hamburg, Annals of Oncology Vol 11(Suppl 4), 152, Kluwer, 2000.
B17. Turkish Brachytherapy Group. “Current status of brachytherapy facilities and applications in Turkey: A survey of Turkish

Brachytherapy Group (Poster)”, Annual Brachytherapy Meeting GEC-ESTRO, Lübeck, Germany, 2003.
B18. Kömürcü Ş, Abstract A, Arpacı F, Öztürk İ, Yılmaz İ, Ayta H, Yavuz AA, Pak Y, Yalçın A. ''Prevalance of physical symptoms among breast cancer patients underwent high dose chemotherapy followed by stem cell support'', 12th International Symposium on Supportive Care in Cancer, MASCC and ISOO, Washington, DC, USA, Supportive Care in Cancer Vol 8 (3), P-68, Springer, 2000.
B19. Yavuz AA, Atatahan İL, Yavuz MN, Akyol F., “Radiotherapy with carbogen breathing and nicotinamide in locally advanced non-small cell lung cancer”, The European Cancer Conference (ECCO 9), Hamburg, 1997.
B20. Pellanda AF, Ozsahin M, Alexandre ED, Kreng M, Van Voutte P, Richetti A, Villa S, Kuten A, Jassem J, Bolla M, Hoogenraad WJ, Vaneijkeren M.gb, Poortmans P, Coolon T, Yavuz AA, Chan S , Landmann C, Kirkore-Houssiav C, Scandolaro L, Bernier J, Juelke P, Bosmam C, Mirimanoff RO, ''Primary Uterine Leiomyosarcoma : Outcome and Prognostic Factors in Eighty Consecutive Patients. A Rare Cancer Network Study (Poster)'', 43'rd ASTRO Annual Meeting, San Francisco, Int J Radiat Oncol Biol Phys, Vol 51(3), Supp 1, 336, Elsevier, 2001.
B21. Yavuz MN, Yavuz AA, Yaris E, Sener M, Ulku C, Karslioglu I. Protection of radiation-induced injury of the epiphyseal growth plate: fractionation alone compared to melatonin pretreatment (Poster). 24th Winter Meeting of the EORTC-PAMM Group, Florence, Italy, 2003.
B22. Komurcu S, Turhal S, Altundag K, Atahan L, Turna HS, Manavoglu O, Yavuz AA, Ozkok S, Aliustaoglu M, Altınbas M, Pak Y, Cooper R, Yaylacı M, Demirkan B, Engin K, Ozdemir F. Turkish Oncology Group, Supportive Care Study Group. A clinical evaluation of transdermal fentanyl (TTS-F) in adults with cancer pain: phase IV, multicentre trial (Poster). 4th Congress of EFIC-The European Federation of the International Association for the Study of Pain Chapters Pain In Europe IV, Prague, Czech Pepublic, 305, 2003.
B23. Topkan E, Onal C, Yavuz M, Kotek A, Efe E, Yavuz AA : Comparison of CT and PET-CT based planning of radiation therapy in locally advanced pancreatic carcinoma. (Oral presentation)7th Congress of the Balkan Union of Oncology. October 15-18, 2008, Kusadasi, Türkiye.
B24. Topkan E, Onal C, Yavuz AA, Yuksel O, Efe E, Yavuz M: Three-dimensional conformal radiation therapy boost for cervical cancer in place of intracavitary brachytherapy. (Oral presentation)7th Congress of the Balkan Union of Oncology. October 15-18, 2008, Kusadasi, Türkiye.
B25. Onal C, Topkan E, Efe E, Yavuz M, Sonmez S, Yavuz AA: Comparison of Rectal Volume Definition Techniques and Their Influence on Rectal Toxicity in Patients with Prostate Cancer Treated with 3D Conformal Radiotherapy. (Oral presentation), 7th Congress of the Balkan Union of Oncology. October 15-18, 2008, Kusadasi, Türkiye.
B26. Onal C, Topkan E, Arslan G, Yavuz AA, Sonmez A, Yavuz M: The Effect of Neoadjuvant and Concurrent Hormonal Therapy on Prostate Volume and Critical Organ Doses in Prostate Cancer Patients Treated with Three Dimensional Conformal Radiation Therapy. (Oral presentation) 7th Congress of the Balkan Union of Oncology. October 15-18, 2008, Kusadasi, Türkiye.
B27. Topkan E, Onal C, Yavuz AA, Oymak E, Yavuz M: Prophylactic cranial irradiation in recursive partitioning analysis group 1 patients with locally advanced non-small cell lung cancer. (Poster) 7th Congress of the Balkan Union of Oncology. October 15-18, 2008, Kusadasi, Türkiye.
B28. Onal C, Arslan G, Topkan E, Yavuz M, Yavuz AA: Comparision of Conventional Plan with CT-Guided Plan in Cervical Cancer Patients Treated with Intracavitary Brachytherapy: Dose-Volume Analysis of the Target and Normal Tissues. (Poster) 7th Congress of the Balkan Union of Oncology. October 15-18, 2008, Kusadasi, Türkiye.
B29. The Evaluation of the Efficacy of Chemoradiotherapy(CRT) following Neo-adjuvant Treatment with Docetaxel(T)-Cisplatin(P) in Undifferentiated and Nonkeratinized Squamous Cell Carcinoma of the Nasopharynx - Phase IV Clinical Trial: A Turkish Oncology Group Study. Uzel O., Ozyar E., Pak Y., Altun M., Kaplan B., AKSU M. G., et al. 51st Annual Meeting of the American-Society-for-Radiation-Oncology, Chicago, United States, 1 - 05 November 2009, vol.75, p.3
B30. Patterns of Care for Lung cancer in Radiation Oncology departments of Turkey. Demiral A. N., Alicikus Z. A., Ugur V. I., Karadogan I., Yoeney A., Andrieu M. N., et al. 25th. Annual ESTRO Meeting, Leipzig, Germany, 8 - 12 October 2006, vol.81.

B31. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ c30 and H&N 30: Turkish oncology group, head and neck working party study. Cengiz M., Ozyar E., Esassolak M., Altun M., Akmansu M., Sen M., et al. 23rd Annual Meeting of the European-Society-for-Therapeutic-Radiology-and-Oncology, Amsterdam, Netherlands, 24 - 28 October 2004

B32. RT technique can be important on survival in patients with gastric cancer t

readted with postoperative chemoradiotherapy .ŞİRİN ÖZDEMİR, B., YAVUZ, AA., AKSU, M. G., & ÇEÇEN, Y., (2016). RSNA 2016 (pp.1). Chicago, United States of America

C. Articles published in national peer-reviewed journals:
C1. Yavuz AA, Aydın F, Yavuz MN, “Conventional Treatment and Follow-up Principles in Stage II Breast Cancer (Review)”, Clinical Development, 12, 725-727 (1999).
C2. Yavuz MN, Yavuz AA, Kavgacı H, Ilis E, Aydin F, Çakırbay H.,''Effects of pamidronate use on the palliative radiotherapy of bone metastases'', Turkish Journal of Cancer, 32(2), 57-65 (2002 ).
C3. Abstract A, Arpacı F, Öztürk B, Camcı C, Safalı M, Kömürcü Ş, Güleç B, Yılmaz İ, Ayta H, Yavuz AA, Pak Y, Yücel İ, Yalçın A., ''Results of high dose chemotherapy and autologous peripheral blood stem cell transplantation in 45 patients with breast cancer'', Turkish Journal of Cancer, 30(4), 139-147 (2000).
C4. Abstract A, Beyzadeoğlu M, Tezcan Y, Arpacı F, Öztürk B, Yavuz AA, Kömürcü Ş, Yılmaz Mİ, Oysul K, ''A retrospective analysis of 32 locally advanced nasopharyngeal carcinoma patients treated with chemotherapy and radiotherapy'', Turkish Journal of Cancer, 31(3), 106-113 (2001).
C5. Baş M, Gürsoy O, Alkaya F, Ayar H, Yavuz AA. “The use of pure lead instead of lipowitz alloy in radiotherapy applications and a newly-developed mold apparatus”, Eastern Journal of Medicine 4(2), 73-76 (1999).
C6. Yavuz MN., Yavuz AA., “Oral complications in cancer treatment: Mucositis, oral infection, dry mouth and taste disorder”, Hematology-Oncology, 3(3), 197-203 (2001).
C7. Race N, Yavuz MN, Yavuz AA, Ökten A., ''Assesment of Quality of Life in Pediatric Cancer Patients at Diagnosis and During Therapy'', Turkish Journal of Cancer, 31(4), 139-149 (2001).
C8. Abstract A, Yavuz AA, Beyzadeoglu M, Özgök Y, Öztürk B, Arpacı F, Kömürcü S, Yamanel L, Doğru T. ''Resection of retroperitoneal residual mass after chemotherapy in patients with nonseminomatous testicular cancer'', Turkish Journal of Cancer, 31(2), 57-62 (2001).
C9. Baş M, Baş B, Telatar M, Değer O, Özlü T, Yavuz AA. “The role of the tumor marker Cyfra 21.1 in the evaluation of response to radiotherapy in non-small cell lung cancers”, Respiratory Diseases, 11(1), 70-77 (2000).
C10. Yavuz MN, Yavuz AA, Genc M, Kucuktulu E, Colak F, Bahat Z, Cimsitoglu E. "Our radiotherapy results in adult glial tumors: retrospective analysis of 73 patients", Turkish Journal of Hematology Oncology, 13(2), 72-78 (2003).
C11. Yavuz AA, Onal C. 'Radiotherapy in Small Cell Lung Cancer'. Turkiye Klinikleri Journal of Chest Diseases, November (2003).
C12. Genc M, Bahat Z, Yavuz MN, Cimşitoglu E, Küçüktülü E, Çolak F, Yavuz AA. 'Our Radiotherapy Results in Soft Tissue Sarcomas'. Turkish Journal of Hematology Oncology, 14(2), 74-79 (2004).
C13. Topkan E, Yavuz M.N, Yavuz AA: Bystander effect due to radiotherapy. Occurrence mechanisms and potential clinical implications. EnglishJ Oncol. 2007 22(3):146-152.

C14. Kaya V, KORCUM AF, Yıldırım M, AKSU MG, ÖZDEMİR BS, Mutlu H, YAVUZ AA. Prognostic factors in gastric cancer patients undergoing adjuvant chemoradiotherapy. Acıbadem University Journal of Health Sciences, 2015. Vol 6, No 1, Ps:21-24.

C15. Topkan E, Önal C, Yavuz AA, Yavuz M: Pathophysiology and Management Of Radiation-Induced Lumbosacral Plexopathy. Turkish J Oncol 23(3):146-152 (2008).
C16. Yavuz AA., "The Role of Prophylactic Brain Irradiation in the Treatment of Small Cell Lung Cancer (Selective Literature)", Hematology-Oncology 2(3), 258-259 (2000).
C17. Kaya V, Korcum AF, Aksu MG, Mutlu H, ÖZDEMİR BS, YAVUZ AA.
Prognostic factors in gastric cancer patients undergoing adjuvant chemoradiotherapy. Acıbadem University Journal of Health Sciences, 2015. Vol 6, No 1, Ps: 22-27.

D. Papers presented at national scientific meetings and published in proceedings books:
D1. Yavuz AA, Akyol F, Özyar E, Gürkaynak M, Hoşal Ş, Atahan IL, Hoşal N. “Primary radiotherapy in early stage laryngeal cancers”, II. National Radiation Oncology Congress, Ürgüp, Volume 1. (SB-60), page: 97, 1996.
D2. Yavuz AA, Uzal D, Özyar E, Atahan IL. "Radiotherapy in a case of recurrent eyelid rhabdomyosarcoma", II. National Radiation Oncology Congress, Ürgüp, Volume 1. (P-59), page: 177, 1996.
D3. Yavuz AA, Aydın F, Yavuz MN, İliş E, Bahat Z, Uzuner H. "Comparison of conventional therapy and octreotide use in the treatment of acute radiation enteritis", XIII. National Cancer Congress. Antalya. Volume 1. (P-238), p. 85, 1999.
D4. Akyol F, Özyar E, Hoşal S, Yavuz AA. "External radiotherapy and interstitial HDR brachytherapy in early stage free tongue tumors", II. National Radiation Oncology Congress, Ürgüp, Volume 1. (P-14), page: 132, 1996.
D5. Yavuz AA, Zorlu F, Akyol F, Atahan IL. "Clinical use of carbogen and nicotinamide as a radiation sensitizing method: feasibility and toxicity", II. National Radiation Oncology Congress, Ürgüp, Volume 1. (SB-38), page: 75, 1996.
D6. Yavuz AA, Özyar E, Nabei N, Cila A, Uzal D, Yavuz MN, Gököz A. ''SternuA case of eosinophilic granuloma located in m”, II. National Radiation Oncology Congress, Ürgüp, Volume 1. (P-88), page: 206, 1996.
D7. Yılmaz M, Aydın F, Yavuz AA, Özdemir F, Yavuz MN, Kavgacı H. "Comparison of serum IL-2, IL-6 and IL-10 values in patients with Aggressive Non-Hodgkin Lymphoma with international prognostic index criteria", XIV. National Cancer Congress, Istanbul, Volume 1. (SB-17), page: 92, 2001.
D8. Yavuz MN, İliş E, Çolak F, Cimşitoğlu E, Bahat Z, Treer T, Yavuz AA. Radiotherapy with accelerated fractionated concomitant boost technique in locally advanced bladder cancer. V. National Radiation Oncology Congress, Kuşadası, Aydın, Volume 1. (BTP-2), page: 222, 2002.
D9. Race N, Yavuz MN, Yavuz AA, Ökten A. Evaluation of quality of life in children with cancer, XIV. National Cancer Congress, Istanbul, Volume 1. (SB-13), page: 83, 2001.
D10. Aydın F, Özdemir F, Kavgacı H, Ovalı E, Yavuz AA, Yavuz MN. “The effects of farnesyl transferase inhibitor L-744,832 and radiotherapy on H-Ras + (SVR A221A) cell line”, XV. National Cancer Congress, Antalya, Volume 1. (P-535), page: 188, 2003.
D11. Yavuz AA, Cimşitoğlu E, Yavuz MN, Çolak F, Küçük A, İskender S. The effects of vacuum immobilization bed use on set-up errors in thoracic irradiation. IV. National Radiation Oncology Congress, Bursa, Volume 1. (SB-36), page: 62, 2000.
D12. Kömürcü Ş, Abstract A, Arpacı F, Öztürk B, Yılmaz İ, Yavuz AA, Pak Y, Yalçın A. “The frequency of physical symptoms in breast cancer patients who received high-dose chemotherapy and stem cell support”, XIV. National Cancer Congress, Istanbul, Volume 1. (PO-4), page: 159, 2001.
D13. Küçüktülü E, Yavuz MN, İliş ET, Çolak F, Bahat Z, Cimşitoğlu E, Yavuz AA. "Our radiotherapy results in adult glial tumors: A retrospective analysis of 73 patients", XV. National Cancer Congress, Antalya, Volume 1. (P-497), page: 176, 2003.
D14. Yavuz AA, Ovalı E, İliş E, Aydın F, Uzuner H, Yavuz MN. “The effect of megesterol acetate use on serum IL-1 beta and TNF-alpha cytokine levels in cachectic cancer patients receiving radiotherapy”, National Cancer Congress, Istanbul, Volume 1. (PO-2), page: 162, 2001.
D15. Çan G, Yavuz MN, Togan T, Yavuz AA., Kapucu M. "The risk of breast cancer in women over 35 in Trabzon", XIV. National Cancer Congress, Istanbul, Volume 1. (PO-1 ME), page: 110, 2001.
D16. Yavuz MN, Güler G, Yavuz AA, İliş E, Ruacan Ş. “Radiotherapy in a case of malignant fibrous histiocytoma located in the urethra”, IV. National Radiation Oncology Congress, Bursa, Volume 1. (P-86), page: 154, 2000.
D17. Abstract A., Arpacı F, Yılmaz İ, Ayta H, Öztürk B, Kömürcü Ş, Yavuz AA., Tezcan Y, Açıkel C, Özata M. “Effect of tamoxifen on serum leptin level in patients with breast cancer”, XIV. National Cancer Congress, Istanbul, Volume 1. (PO-1 ME), page: 112, 2001.
D18. Yavuz MN, İliş E, Yavuz AA, Çakırbay H, Uzuner H, Aydın F, “The Use of Pamidronate in Addition to Standard Palliative Radiotherapy in the Treatment of Bone Metastases: A Prospective Randomized Study”, IV. National Radiation Oncology Congress, Bursa, Volume 1. (P-89), page: 157, 2000.
D19. Yavuz MN, Reis A, Yavuz AA, İliş A, Özgür GK, Aydın F, Özoran Y. “Effect of Retinoblastoma Protein Expression on Radiotherapy Response in Bladder Cancers”, IV. National Radiation Oncology Congress, Bursa, Volume 1. (P-92), page: 160, 2000.
D20. Ovali E, Aydın F, Özdemir F, Yavuz AA, Kavgacı H, Yavuz MN. “Effects of Dexamethasone, Atra, Vit D and Interferon on Fo Myeloma cells”, XIV. National Cancer Congress, Istanbul, Volume 1. (PO-3), page: 220, 2001.
D21. Yavuz AA, Reis A, Yavuz MN, Sarı A, Bahat Z, Aydın F. "Primitive Neuroectodermal Tumor Located in the Primary Spinal Region: A Case Report", IV. National Radiation Oncology Congress, Bursa, Volume 1. (P-88), page: 156, 2000.
D22. Yavuz MN, Cimşit G, Yavuz AA, Turgutalp H, Bahat Z. "An Atypical Skin Lesion Due to Radiation: Verruca Vulgaris in the Treatment Area", IV. National Radiation Oncology Congress, Bursa, Volume 1. (P-91), page: 159, 2000.
D23. Aydın F, Ovali E, Yavuz AA. “Endogenous granulocyte colony stimulating factor (G-CSF) levels in neutropenic patients due to chemotherapy and primary disease”, XIII. National Cancer Congress, 27 April-1 May 1999, Antalya, Volume 1. (SB-16), page: 4, 1999.
D24. Alkaya F, Bones G, Chief M, Yavuz MN, Gürsoy TO, Yavuz AA. “The effect of protection blocks used in radiotherapy applications with Co-60 device on dose parameters”, III. National Radiation Oncology Congress, Istanbul, Turkish Journal of Oncology, 13(3), (SB-2), page: 83, 1998.
D25. Yavuz AA, Bahat Z, Kavakçı Ö, Yavuz MN, Uzuner H, Bilici M. "Radiotherapy in geriatric patients: Effects on nutrition, physical performance, comorbidity, psychosocial functions and quality of life", IV. National Radiation Oncology Congress, 26-29 March 2000, Bursa, Vol. 1. (P-94), page: 162, 2000.
D26. Baş M, Gürsoy O, Alkaya F, Ayar H, Yavuz AA. “The use of pure lead instead of Lipowitz alloy in radiotherapy applications and a newly developed mold d

Ünegi”, 3rd National Radiation Oncology Congress, Istanbul, Turkish Journal of Oncology, Vol 13(3), (P-1), page: 121, 1998.
D27. İliş ET, Yavuz AA, Yavuz MN, Bülbül Y, Kavgacı H, Öztuna F, Özdemir F, Özlü T, Aydın F. "Comparison of simultaneous additional dose accelerated hyperfractionated radiotherapy and simultaneous chemoradiotherapy in non-small cell lung cancers", XV . National Cancer Congress, Antalya, Volume 1. (SB-3, P-038), pp: 33-34, 2003.
D28. Kömürcü S, Turhal S, Altundağ K, Atahan İL, Turna H, Manavoğlu O, Yavuz AA, Özkök S, Aliustaoğlu M, Altınbaş M. ''A clinical evaluation of transdermal fentanyl in adults with cancer pain: phase IV, multicenter trial' ', XV. National Cancer Congress, Antalya, Volume 1. (P-079), page: 48, 2003.
D29. Yavuz AA, Yavuz MN, Ülkü C, Racing E, Şener M, Runner P, Karslıoğlu İ. “The role of melatonin use in the prevention of radiotherapy-induced epiphyseal damage”, XV. National Cancer Congress, Antalya, Volume 1. (P-484), page: 172, 2003.
D30. Küçüktülü E, Genç M, Kavgacı H, Bahat Z, Özdemir F, Yavuz MN, Yavuz AA. 'Concurrent chemoradiotherapy in gastric carcinomas', VI. National Radiation Oncology Congress, Antalya, Volume 1. (P-32), page: 148, 2004.
D31. Yavuz AA. 'Effects of amifostine and melatonin in the prevention of radiotherapy-induced cardiac injury'. VI. National Radiation Oncology Congress, Antalya, Volume 1. (P-64), page: 180, 2004.
D32. Zengin AY, Canyılmaz E, Cimşitoğlu E, Çolak F, Yavuz MN, Küçüktülü E, Yavuz AA. "Our paraaortic radiotherapy results in testicular seminoma", XVI. National Cancer Congress, Antalya, Volume 1. (P-921), page: 54, 2005.
D33. Yavuz AA, Bahat Z, Genç M, Yavuz MN, Cimşitoğlu E, Küçüktülü E, Çolak F. 'Our radiotherapy results in soft tissue sarcomas'. VI. National Radiation Oncology Congress, Antalya, Volume 1. (P-163), page: 279, 2004.
D34. Küçüktülü E, Canyılmaz E, Cimsitoglu E, Yavuz MN, Çolak F, Bahat Z, Yavuz AA. “Comparison of Concurrent Additional Dose Accelerated Hyperfractionated Radiotherapy and Concurrent Chemoradiotherapy Treatments in Patients with Locally Advanced Stage Non-Small Cell Lung Cancer”, I. National Lung Cancer Congress, Istanbul, November 2004 (Verbal Presentation).
D35. Küçüktülü E, Cimşitoğlu E, Yavuz AA, Çolak F, Canyılmaz E, Zengin AY, Yavuz MN. "Black Sea Technical University, Department of Radiation Oncology, Brachytherapy applications", XVI. National Cancer Congress, Antalya, Volume 1. (P-811), page: 178, 2005.
D36. Hacıislamoğlu E, Atahan IL, Gurdalli S, Yavuz MN, Colak F, Yavuz AA. “Investigation of the effects of cobalt-60 and 6-MV Photon Energies on the dose distribution of different treatment positions in Whole Body Irradiation (TVI)”, VII. National Radiation Oncology Congress, Fethiye, Volume 1. (P-233), page: 170, 2006.
D37. Canyılmaz E, Cobanoğlu U, Yavuz MN, Çan G, Zengin AY, Yavuz AA. “The effect of H-ras Oncogene on radiotherapy response in bladder cancers, VII. National Radiation Oncology Congress, Fethiye, Volume 1. (S-019), page: 72, 2006.
D38. Uzel Ö, Özyar E, Pak Y, Çetingül N, Altun M, Esassolak M, Yavuz AA. ''Chemoradiotherapy application after docetaxel-cisplatin neoadjuvant therapy in undifferentiated and non-keratinized squamous cell nasopharyngeal cancer-Phase IV clinical trial''. VII. National Radiation Oncology Congress, Fethiye, Volume 1. (S-022), page: 73, 2006.
D39. Topkan E, Önal C, Yavuz MN, Yavuz AA: Comparison of the Roles of Amifostine and Melatonin in the Prevention of Radiation-Induced Epiphyseal Growth Plate Damage in the Growing Rat Pineal Model. VIII. National Radiation Oncology Congress (UROK) 19-23.4.2008, Antalya.

D40. Topkan E, Önal C, Yavuz AA, Yavuz MN: The Role of Glutamine in the Prevention of Acute Radiation Esophagitis and Weight Loss in Patients with Non-Small Cell Lung Cancer. Examination of Clinical and Dosimetric Factors. VIII. National Radiation Oncology Congress (UROK) 19-23.4.2008, Antalya.

D41. Topkan E, Önal C, Yavuz AA, Yavuz MN: Comparison of CT and PET-CT Based Radiotherapy Planning in Locally Advanced Pancreatic Cancer: Pilot Study Results. VIII. National Radiation Oncology Congress (UROK) 19-23.4.2008, Antalya.

D42. Önal C, Kötek A, Topkan E, Yavuz AA, Yavuz MN: Solitary Extramedullary Plasmocytoma Localized in Tongue: A Case Report. VIII. National Radiation Oncology Congress (UROK) 19-23.4.2008, Antalya.

D43. Önal C, Yüksel Ö, Topkan E, Yavuz M, Yavuz AA: The Role of 3D-Conformal Radiotherapy in Bilateral Glomus Tumor: A Case Report. VIII. National Radiation Oncology Congress (UROK) 19-23.4.2008, Antalya.

D44. Topkan E, Oymak E, Önal C, Yavuz MN, Yavuz AA: High Grade Glioneuronal Tumor: Case Report. VIII. National Radiation Oncology Congress (UROK) 19-23.4.2008, Antalya.

D45. Önal C, Oymak E, Topkan E, Yavuz M, Yavuz AA: 3D-Conformal Radiotherapy in Spindle Cell Oncocytoma: A Case Report. VIII. National Radiation Oncology Congress (UROK) 19-23.4.2008, Antalya.
D46. Yavuz AA, Erdem R, Topkan E, Bacanlı D, Önal H.C, Yüksel Ö, and Yavuz MN: Radiation-induced epiphyseal plaque in growing ratsThe role of genistein in bee inhibition. XVIII. National Cancer Congress (UKK) 21-26.4.2009, Antalya.
D47. Önal C, Oymak E, Arslan G, Pehlivan B, Topkan E, Yavuz M, and Yavuz AA: Comparison of conventional plane and 3D plane in patients with cervical cancer treated with intracavitary brachytherapy. XVIII. National Cancer Congress (UKK) 21-26.4.2009, Antalya.
D48. Önal C, Kayaseçuk F, Erdem R, Oymak E, Pehlivan B, Topkan E, Yavuz M, Bacanli D, and Yavuz AA: Comparison of the efficacy of melatonin and octreotide in the prevention of radiation enteritis XVIII. National Cancer Congress (UKK) 21-26.4.2009, Antalya.
D49. Pehlivan B, Yavuz M, Topuk S, Topkan E and Yavuz AA:. 18-FDG-PET-CT-based curative radiotherapy in a patient with aggressive osteoblastoma of the cervical spine: A case report. XVIII. National Cancer Congress (UKK) 21-26.4.2009, Antalya.
D50. Sonmez A, Pehlivan B, Arslan G, Yavuz AA, Topkan E, Sonmez S and Yavuz M . Secondary subfield technique with multi-leaf collimator in whole body irradiation. XVIII. National Cancer Congress (UKK) 21-26.4.2009, Antalya.
D51. Yavuz M.N, Pehlivan B, Aydın M, Topkan E, Önal C, Reyhan M, Kötek A, Yapar A.F and Yavuz AA. Comparison of CT and PET-CT-based 3-dimensional conformal radiotherapy planning in preoperative radiotherapy of rectal cancer. XVIII. National Cancer Congress (UKK) 21-26.4.2009, Antalya.
D52. POSTOPPERATIVE CHEMORADIOTHERAPY IN PATIENTS WITH STOMACH CANCER: PROGNOSTIC FACTORS AND SURVIVAL. ŞİRİN ÖZDEMİR B., AKSU M. G., ÇEÇEN Y., YAVUZ A.A. XII. NATIONAL RADIATION ONCOLOGY CONGRESS, Antalya, Turkey, 20 - 24 April 2016, pp.159
D53. POSTOPPERATIVE CHEMORADIOTHERAPY IN PATIENTS WITH STOMACH CANCER: PROGNOSTIC FACTORS AND SURVIVAL. ŞİRİN ÖZDEMİR B., AKSU M. G., ÇEÇEN Y., YAVUZ A.A. XII. NATIONAL RADIATION ONCOLOGY CONGRESS, Antalya, Turkey, 20 - 24 April 2016, pp.159
D54. ELEKTA SYNERGY AND ELEKTA SYNERGY PLATFORM LINEAR ACCELERATOR LONG-TERM PHOTON OUTPUT STABILITY ASSESSMENT. Toykan Çiftlikli Ö., ÇEÇEN Y., Yazgan Ç., SINDIR B., YAVUZ A.A. 15th NATIONAL MEDICAL PHYSICS CONGRESS, Trabzon, Turkey, 16 - 19 May 2015, pp.162
D55. LYMPOPENIA IN PATIENTS WITH LOCAL ADVANCED STAGE LARYNX CANCER APPLIED RT. ŞİRİN ÖZDEMİR B., Bükulmez T., YAVUZ M. N., BOZKURT S., COŞKUN H. Ş., YAVUZ A.A., et al. 21st NATIONAL CANCER CONGRESS, Antalya, Turkey, 22 - 26 April 2015, pp.467
D56. LYMPOPENIA IN PATIENTS WITH LOCAL ADVANCED STAGE LARYNX CANCER APPLIED RT. ŞİRİN ÖZDEMİR B., Bükulmez T., YAVUZ M. N., BOZKURT S., COŞKUN H. Ş., YAVUZ A.A., et al. 21st NATIONAL CANCER CONGRESS, Antalya, Turkey, 22 - 26 April 2015, pp.467
D57. THE RELATIONSHIP WITH LYMPOPENIA IN GBM PATIENTS WITH RT. Bükulmez T., ŞİRİN ÖZDEMİR B., Öztürk D., ÖZEL ERKAN D., KORCUM ŞAHİN A. F., YAVUZ A.A., et al. 21st NATIONAL CANCER CONGRESS, Antalya, Turkey, 22 - 26 April 2015, pp.540
D58. The Relationship between Lymphopenia and Survival in Glioblastoma Multiforme Patients Treated with Radiotherapy. BÜKÜLMEZ T., ÖZDEMİR B. Ş., ÖZTÜRK D., Özel D., KORCUM A. F., YAVUZ A.A., et al. 21st national cancer congress, Antalya, Turkey, 22 - 26 April 2015, pp.40
D59. Bukulmez, T., B.S. Özdemir, D. Öztürk, D. Özel, A. F. Korcum, A.A.Yavuz and M. Genç, “The Relationship between Lymphopenia and Survival in Glioblastoma Multiforme Patients Treated with Radiotherapy. 21st National Cancer Congress, Antalya, Turkey, 19 - 26 April 2015, pp.540.
D60. CN, TC, HI evaluation of DI and other target volume wrap criteria in small area IMRT plans of low and medium risk prostate cancer patients. Karakuş İ., KORCUM A. F., ÇEÇEN Y., AKSU M. G., SINDIR B., Dündar E., et al. 11th National Radiation Oncology Congress, Antalya, Turkey, 23 - 27 April 2014, vol.29, pp.279.
D61. Our postoperative radiotherapy results in cervical carcinoma. Ozdemir B. S., AKSU M. G., KORCUM A. F., BÜKÜLMEZ T., Karakuş İ., ŞİMŞEK T., et al. XI. National Radiation Oncology Congress, Antalya, Turkey, 23 - 27 April 2014, vol.29, pp.204.
D62. Clinicopathological prognostic factors in gastric cancer patients treated with adjuvant radiotherapy. Kaya V., KORCUM A. F., AKSU M. G., Ozdemir B. S., Yıldırım M., YAVUZ A.A. 11th National Radiation Oncology Congress, Antalya, Turkey, 23 - 27 April 2014, vol.29, pp.198.
D63. COMPARISON OF IMRT PLANS AND PATIENTS WITH ENDOMETRIUM CANCER. Bidari V., CAN Z. R. Ö., ŞİRİN ÖZDEMİR B., TOYKAN ÇİFTLİKLİ Ö., Bükülmez T., DÜNDAR E., et al. XI. NATIONAL RADIATION ONCOLOGY CONGRESS, Antalya, Turkey, 19 - 23 April 2014, pp.299.
D64. Radiotherapy in Locally developed pancreatic cancer. Kaya V., KORCUM A. F., Yıldırım M., AKSU M. G., Ozdemir B. S., YAVUZ A.A. 3rd International Gastrointestinal Cancer Conference, Antalya, Turkey, 13 - 15 December 2013, pp.9.
D65. Radiotherapy in Locally Advanced Pancreatic Cancer. Kaya V., KORCUM A. F., Yıldırım M., AKSU M. G., Ozdemir B. S., YAVUZ A.A. 20. National Cancer Congress, Antalya, Turkey, 21 - 24 April 2013, pp.150.
D66. Linac-Based Postoperative Radiotherapy Results in Patients with Non-Small Cell Lung Cancer. Mersin Çeçen S., YAVUZ A.A., AKSU M. G., ÇEÇEN Y., ÖZDEMIR B. Ş., TUNÇEL N., et al. 20. National Cancer Congress, Antalya, Turkey, 19 - 23 April 2013, pp.204-205.
D67. Linac-Based Postoperative Radiotherapy Results in Patients with Non-Small Cell Lung Cancer. Mersin Çeçen S., YAVUZ A.A., AKSU M. G., ÇEÇEN Y., ÖZDEMİR B. Ş., TUNÇEL N., et al. 20. National Cancer Congress, Antalya, Turkey, 19 - 23 April 2013, pp.204-205.
D68. Postoperative Radiotherapy in Endometrial Cancer: Prognostic Factors and Survival Review. KORCUM A. F., Mersin Çeçen S., Toykan Çiftlikli Ö., GENÇ M., AKSU M. G., Karakuş İ., et al. X.National Radiation Oncology Congress, Antalya, Turkey, 19 - 23 April 2012, pp.254.
D69. Whole Body Irradiation (TVI) in Sitting Position and In-Vivo Dosimetry with Semiconductor Diodes. ÇEÇEN Y., SINDIR B., AKSU M. G., ÖZDEMİR B. Ş., TUNÇEL N., YAVUZ M. N., et al. 10. National Radiation Oncology Congress, Antalya, Turkey, 19 - 23 April 2012, pp.231.
D70. Interindividual differences in clinical target volume definition for post-prostatectomy radiotherapy. AKSU M. G., KORCUM A. F., Ozdemir B. S., YAVUZ A.A., GENÇ M., Mersin Çeçen S., et al. X.National Radiation Oncology Congress, Antalya, Turkey, 19 - 23 April 2012, pp.124.
D71. Comparison of Intensity Modulated Radiotherapy and 3D Radiotherapy in terms of Pituitary, Temporomandibular Joint and Cochlea Doses in Patients with Nasopharyngeal Cancer. GENÇ M., ÇEÇEN Y., Mersin Çeçen S., SINDIR B., Ozdemir B. S., Pehlivan B., et al. 10. National Radiation Oncology Congress, Antalya, Turkey, 19 - 23 April 2012, pp.156-157.
D72. Postoperative radiotherapy results in 62 patients with non-small cell lung carcinoma treated with Linear Accelerator. MERSİN S., Pehlivan B., Ozdemir B. S., ÇEÇEN Y., AKSU M. G., TUNÇEL N., et al. V.National Lung Cancer Congress, Antalya, Turkey, 23 - 26 February 2012, pp.15.
D73. Tm volume changes in Radiotherapy of SCLC: Is there a role for adaptive RT? ŞİRİN ÖZDEMİR B., DÜNDAR E., Karakuş İ., Keser H., GENÇ M., AKSU M. G., et al. IX. NATIONAL RADIATION ONCOLOGY CONGRESS, Kyrenia, Cyprus (North Cyprus), 21 - 25 April 2010, pp.99.
D74. Treatment approach in cervical cancer in Radiation Oncology Departments: TOG study. Okkan S., Özsaran Z., Güney Y., Eren M., Salman A., Küçük p., et al. 9th National Radiation Oncology Congress, Kyrenia, Turkey, 21 - 25 April 2010, pp.162.
D75. Application of Chemoradiotherapy after Docetaxel-Cisplatin Neoadjuvant Therapy in undifferentiated and non-keratinized squamous cell nasopharyngeal cancer - Phase IV Clinical study. Uzel O., Ozyar E., Pak Y., Altun M., Kaplan B., AKSU M. G., et al. VII. National Radiation Oncology Congress, Muğla, Turkey, 19 - 23 April 2006, pp.73.
D76. NAZOHAYAT: Evaluation of Quality of Life in Patients with Nasopharyngeal Cancer with EORTC QLQ C30 and H&N30 Module, Turkish Oncology Group - Head and Neck Tumors Subgroup Study. Cengiz M., Ozyar E., Esassolak M., Altun M., Akmansu M., Sen M., et al. VI. National Radiation Oncology Congress, Antalya, Turkey, 21 - 25 April 2004, pp.102.